SMAD4 and ACVR2A, which are involved in TGF-β signaling, and histone-modifiers MLL3 and HDAC1 are among the top genes showing multiple mutation types in the inferred pancreatic cancer network (Fig. 6c), which is consistent with a previous study40. This evidence concerns the gene HDAC1 and familial pancreatic carcinoma.